scholarly journals Prostate cancer and the unfolded protein response

Oncotarget ◽  
2016 ◽  
Vol 7 (33) ◽  
pp. 54051-54066 ◽  
Author(s):  
Margrethe Storm ◽  
Xia Sheng ◽  
Yke Jildouw Arnoldussen ◽  
Fahri Saatcioglu
PLoS ONE ◽  
2012 ◽  
Vol 7 (10) ◽  
pp. e45690 ◽  
Author(s):  
Danilo Maddalo ◽  
Antje Neeb ◽  
Katja Jehle ◽  
Katja Schmitz ◽  
Claudia Muhle-Goll ◽  
...  

2009 ◽  
Vol 28 (1-2) ◽  
pp. 219-223 ◽  
Author(s):  
Alex Yick-Lun So ◽  
Erwin de la Fuente ◽  
Peter Walter ◽  
Marc Shuman ◽  
Sebastián Bernales

Oncogene ◽  
2019 ◽  
Vol 38 (35) ◽  
pp. 6301-6318 ◽  
Author(s):  
Nora Pällmann ◽  
Marte Livgård ◽  
Martina Tesikova ◽  
Hatice Zeynep Nenseth ◽  
Erman Akkus ◽  
...  

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Francesca Amoroso ◽  
Kimberley Glass ◽  
Reema Singh ◽  
Francisco Liberal ◽  
Rebecca E. Steele ◽  
...  

AbstractProstate cancer (PCa) is the most common non-cutaneous cancer in men and a notable cause of cancer mortality when it metastasises. The unfolded protein response (UPR) can be cytoprotective but when acutely activated can lead to cell death. In this study, we sought to enhance the acute activation of the UPR using radiation and ONC201, an UPR activator. Treating PCa cells with ONC201 quickly increased the expression of all the key regulators of the UPR and reduced the oxidative phosphorylation, with cell death occurring 72 h later. We exploited this time lag to sensitize prostate cancer cells to radiation through short-term treatment with ONC201. To understand how priming occurred, we performed RNA-Seq analysis and found that ONC201 suppressed the expression of cell cycle and DNA repair factors. In conclusion, we have shown that ONC201 can prime enhanced radiation response.


Sign in / Sign up

Export Citation Format

Share Document